Radius Initiates Phase 2 Study of BA058-Transdermal for the Treatment of Postmenopausal Osteoporosis
CONTACT:
Radius Health
Corporate
Nick Harvey
CFO
617-551-4700
LaVoie Group
Media & Investors
Amanda Murphy
978.745.4200 ext. 107
amurphy@lavoiegroup.com


